Vaccine demonstrates potential in delaying relapse of KRAS-mutated pancreatic and colorectal cancers

A vaccine has shown potential to prevent relapse of KRAS-mutated pancreatic and colorectal cancers for patients who had previously undergone surgery, according to a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center. Results are published in Nature Medicine.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart